期刊文献+

大脑胶质瘤病的临床病理学特征:病例报告及文献综述 被引量:9

Clinicopathological features of gliomatosis cerebri:a case report and review of literatures
下载PDF
导出
摘要 目的探讨大脑胶质瘤病的临床病理学特征。方法对1例大脑胶质瘤病患者的临床表现、影像学、组织病理学和免疫组织化学特征进行回顾性分析,并且复习相关文献。结果男性患者,24岁。临床表现为发作性黑蒙和发作时意识丧失性癫癎症状,以及随后出现的不能缓解的剧烈头痛。MRI显示左侧颞顶叶-基底节区弥散性不规则稍高信号,局灶信号不均匀,无明显占位效应;MRS显示病灶区Cho/NAA比值明显升高。手术切除部分左侧颞叶及海马组织,光学显微镜下观察肿瘤细胞呈轻至中等密度增生,弥漫性浸润;呈星形胶质细胞样形态,胞核为长梭形或纺锤形,染色质轻度深染;核分裂象罕见;未见微血管增生和坏死;肿瘤细胞排列形成明显的继发性结构,包括软脑膜下和室管膜下肿瘤细胞密集生长、血管周围肿瘤细胞聚集及神经元卫星现象等;灰质与白质分界不清,但神经元分布结构基本保留。免疫组织化学染色肿瘤细胞胶质纤维酸性蛋白和S-100蛋白表达阳性,少突胶质细胞系转录因子-2、突触素和神经元核抗原表达阴性;TP53过表达,约8%;Ki-67抗原标记指数约为10%。结论大脑胶质瘤病为临床少见、可累及多个脑叶的弥漫浸润性肿瘤,影像学上无明显占位效应,MRI和MRS检查可提示诊断。肿瘤细胞弥漫性浸润并形成明显的继发性结构,需与多中心/多灶性胶质瘤和脱髓鞘病变等相鉴别。TP53和Ki-67抗原标记指数可资与非肿瘤性病变相鉴别。 Objective To explore the. clinicopathological features of gliomatosis cerebri. Methods The clinical manifestations, neuroimaging, histopathologieal and immunohistoehemical features were analysed in one case of gliomatosis cerebri. Related literatures were reviewed. Results A 24-yearold man presented with a seizure which started as paroxysmal amaurosis and progressed to loss of consciousness and severe headache. The magnetic resonance imaging (MRI) showed a diffuse slight hyperintensity in the left temporoparietal and basal ganglial region. The magnetic resonance spectroscopy (MRS) showed an increased Cho/NAA ratio. The patient subsequently underwent a eraniotomy with part of left temporal tissue and hippoeampus resection. Microscopically, there was diffuse infiltration of the brain parenchyma by low to moderate cellularity of astrocyte-like cells with elongated, fusiform and mildly hyperchromatic nuclei. Mitotic figure was rare. Microvascular proliferation and necrosis were absent. Secondary structures, including subpial and subependymal condensation, perivascular aggregates and perineuronal satellitosis were evident. The distinction between grey and white matter was blurred. There was very little destruction of the pre-existing parenchyma. On immunohistochemical examination, the neoplasm was reactive for glial fibrillary acidic protein (GFAP), S-lO0 protein (S-100) and negtive for oligodendrocyte lineage transcription factor 2 (Olig-2), synaptophysin (Syn) and neuronal nuclei (NeuN). TP53 protein was overexpressed in 8% of tumor cells. Ki-67 antigen labeled index was about 10%. Conclusion Gliomatosis cerebri is an unusual and aggressive glial neoplasm with infiltrative involvement of at least three cerebral lobes. There is minimal mass effect by neuroimaging, but MRI and MRS findings can suggest the diagnosis of gliomatosis cerebri. Histologically, the tumor cells are diffuse infiltrative and may form secondary structures. The differential diagnosis include muhicentric/muhifocal glioma and demyelinating disease and so on. TP53 immunoreactivity and increased Ki-67 antigen labeled index are important for distinguishing gliomatosis cerebri from other non- neoplastic diseases.
出处 《中国现代神经疾病杂志》 CAS 2011年第2期242-248,共7页 Chinese Journal of Contemporary Neurology and Neurosurgery
关键词 脑肿瘤 神经胶质瘤 病理学 磁共振成像 免疫组织化学 Brain neoplasms Glioma Pathoiogy Mggnetie resonance imaging Immunohistochemistry
  • 相关文献

参考文献37

  • 1只达石,于士柱.中枢神经系统肿瘤1993年和2000年两次WHO分类的比较[J].现代神经疾病杂志,2003,3(1):7-12. 被引量:41
  • 2Perkins GH, Schomer DF, Fuller GN, et al. Gliomatosis eerebri: improved outcome with radiotherapy, Int J Radiat Oncol Biol Phys, 2003, 56:1137-1146.
  • 3Vates GE, Chang S, Lamborn KR, et at. Gliomatosis cerebri: a review of 22 cases. Neurosurgery, 2003. 53:261-271.
  • 4Jennings MT, Frenchman M, Shehab T, et al. Gliomatosis cerebri presenting as intractable epilepsy during early childhood. J Child Neurol, 1995, 10:37-45.
  • 5Taillibert S, Chodkiewicz C, Laigle - Donadey F, et al. Gliomatosis cerebri: a reviewof 296 cases from the ANOCEF database and the literature. J Neurooncol, 2006, 76:201-205.
  • 6Asada T, Takayama Y, Tokuriki Y. et al. Gliomatosis cerebri presenting as a parkinsonian syndrome. J Neuroimaging, 2007, 17:269-271.
  • 7Duron E, Lazareth A, Gaubert JY. et al. Gliomatosis eerebri presenting as rapidly progressive dementia and parkinsonism in an elderly woman: a case report. J Med Case Reports, 2008, 2: 53.
  • 8Akimoto J, Nishioka H, Miki T, et al. Clinical diagnosis of gliomatosis cerebri: report of three cases. Brain Tumor Pathol, 2004, 21:87-95.
  • 9Peretti-Viton P, Brunel H, Chinot O, et al. Histological and MR correlations in gliomatosis cerebri. J Neurooncol, 2002, 59:249- 259.
  • 10Yang S, Wetzel S, Law M, et al. Dynamic contrast-enhanced T2*- weighted MR imaging of gliomatosis cerebri. AJNR Am J Neuroradiol, 2002, 23:350-355.

二级参考文献3

共引文献52

同被引文献65

  • 1刘仲涛,田继辉,王圆庆,何鹏,陈鹏飞,张福强.颞下经小脑幕入路切除岩斜区肿瘤的临床研究[J].宁夏医科大学学报,2013,35(6):644-647. 被引量:2
  • 2Benesch M Eder HG Sovinz P Raith J Lackner H Moser A Urban C.Residual or recurrent cerebellar low-grade glioma in children after tumor resection: is re-treatment needed? A single center experience from 1983 to 2003[J].中国神经肿瘤杂志,2006,4(3):204-204. 被引量:15
  • 3Watanabe T, Nobusawa S, Kleihues P, et al. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am J Pathol, 2009, 174:1149-1153.
  • 4Zhao S, Lin Y, Xu W, et al. Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha. Science, 2009, 324:261-265.
  • 5Hartmann C, Meyer J, Balss J, et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol, 2009, 118:469-474.
  • 6Ichimura K, Pearson DM, Kocialkowski S, et al. IDH1 mutations are present in the majority of common adult gliomas but rare in primary glioblastomas. Neuro Oncol, 2009, 11:341-347.
  • 7Sanson M, Marie Y, Paris S, et al. Isocitrate dehydrogenase 1 codon 132 mutation is an important prognostic biomarker in gliomas. J Clin Oncol, 2009, 27:4150-4154.
  • 8杨志波.大脑胶质瘤病的分型研究.兰州大学,2013.
  • 9Chen S, Tanaka S, Giannini C, Morris J, Yan ES, Buckner J, Lachance DH, Parney IF. Gliomatosis cerebri: clinical characteristics, management, and outcomes. J Neurooncol, 2013, 112:267-275.
  • 10Mattox AK, Lark AL, Adamson DC gliomatosis cerebri to temozolomide radiotherapy. Clin Neurol Neurosurg, 2012, Marked response of and whole brain 114:299-306.

引证文献9

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部